FINNENCE ▪ THE WIRE FILE
THE WIRE · № 80800
News▼ Bearish
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Failed Phase III endpoint for VQW-765 removes a pipeline catalyst for Vanda.
Clinical failure removes a key Vanda pipeline catalyst
CATALYST TO WATCH
Guidance on remaining pipeline programs
MAIN RISK
Further pipeline failures could compound losses
FULL DISPATCH
Phase III clinical study of VQW-765 in adults with social anxiety disorder did not meet its primary endpoint Consistent with prior studies, VQW-765 was safe and well tolerated WASHINGTON, Oct. 14, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provided an...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Big-ticket hospital deals are becoming the M&A story of 20262026-10-14 21:00 UTC
Big-ticket hospital deals are becoming the M&A story of 20262026-10-14 21:00 UTC
→CORRELATIONshares Healthcare
Calls mount for NC attorney general to review ‘rushed’ WakeMed-Atrium merger2026-10-14 21:36 UTC
Calls mount for NC attorney general to review ‘rushed’ WakeMed-Atrium merger2026-10-14 21:36 UTC
←CORRELATIONshares Healthcare
FLSC IPO News - Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO2026-10-14 12:32 UTC
FLSC IPO News - Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO2026-10-14 12:32 UTC
←CORRELATIONshares Healthcare
Owens & Minor Launches New Innovation for the Operating Room2026-10-14 18:00 UTC
Owens & Minor Launches New Innovation for the Operating Room2026-10-14 18:00 UTC
←CORRELATIONshares Healthcare
BVXX IPO News - Cardiac medical device developer BioVentrix withdraws $17 million IPO2026-10-14 18:33 UTC
BVXX IPO News - Cardiac medical device developer BioVentrix withdraws $17 million IPO2026-10-14 18:33 UTC
←CORRELATIONshares Healthcare
Atrium-WakeMed merger terms questioned, calls for transparency on the deal increasing2026-10-14 18:33 UTC
Atrium-WakeMed merger terms questioned, calls for transparency on the deal increasing2026-10-14 18:33 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.